History | Upadacitinib for treating active non-radiographic axial spondyloarthritis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 139 KB)

Published:

01 February 2023

Final draft guidance

Final draft guidance
Final appraisal document (PDF 162 KB)

Published:

15 December 2022
Committee papers (PDF 2.79 MB)

Published:

15 December 2022
Committee papers Technical Briefing Document (PDF 1.08 MB)

Published:

15 December 2022

Invitation to participate

Final scope (PDF 225 KB)

Published:

10 March 2022
Final stakeholder list (PDF 162 KB)

Published:

10 March 2022
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 346 KB)

Published:

10 March 2022
Equality impact assessment (Scoping) (PDF 117 KB)

Published:

10 March 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 246 KB)

Published:

09 November 2021
Draft matrix post referral (PDF 162 KB)

Published:

09 November 2021